Company page

Korro Bio, Inc.

Korro Bio, Inc. is a public company traded under the ticker KRRO in the American market, with a market capitalization of approximately $187.3 million. The company focuses on developing innovative RNA-targeted therapies. Korro Bio aims to address significant unmet medical needs through its advanced research and development efforts.